NO951422L - Farmasöytiske sammensetninger for behandling av osteoporose - Google Patents

Farmasöytiske sammensetninger for behandling av osteoporose

Info

Publication number
NO951422L
NO951422L NO951422A NO951422A NO951422L NO 951422 L NO951422 L NO 951422L NO 951422 A NO951422 A NO 951422A NO 951422 A NO951422 A NO 951422A NO 951422 L NO951422 L NO 951422L
Authority
NO
Norway
Prior art keywords
osteoporosis
treatment
compounds
isokohumulon
cohumulon
Prior art date
Application number
NO951422A
Other languages
English (en)
Norwegian (no)
Other versions
NO951422D0 (no
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO951422D0 publication Critical patent/NO951422D0/no
Publication of NO951422L publication Critical patent/NO951422L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NO951422A 1994-04-12 1995-04-11 Farmasöytiske sammensetninger for behandling av osteoporose NO951422L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7323094 1994-04-12

Publications (2)

Publication Number Publication Date
NO951422D0 NO951422D0 (no) 1995-04-11
NO951422L true NO951422L (no) 1995-10-13

Family

ID=13512179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951422A NO951422L (no) 1994-04-12 1995-04-11 Farmasöytiske sammensetninger for behandling av osteoporose

Country Status (13)

Country Link
US (1) US5604263A (ko)
EP (1) EP0677289B1 (ko)
KR (1) KR950031059A (ko)
AT (1) ATE175575T1 (ko)
AU (1) AU696334B2 (ko)
CA (1) CA2146820A1 (ko)
DE (1) DE69507185T2 (ko)
DK (1) DK0677289T3 (ko)
ES (1) ES2129691T3 (ko)
FI (1) FI951702A (ko)
HU (1) HUT71604A (ko)
NO (1) NO951422L (ko)
TW (1) TW427901B (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142819B2 (en) * 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US7270835B2 (en) * 2001-06-20 2007-09-18 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7901714B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7901713B2 (en) * 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US7815944B2 (en) * 2001-06-20 2010-10-19 Metaproteomics, Llc Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
US20040115290A1 (en) * 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US20040219240A1 (en) * 2001-06-20 2004-11-04 Babish John G. Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
US7205151B2 (en) * 2001-06-20 2007-04-17 Metaproteomics, Llc Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US20090263522A1 (en) * 2001-10-26 2009-10-22 Babish John G Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
US7279185B2 (en) * 2001-10-26 2007-10-09 Metaproteonics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
WO2003068205A1 (fr) 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions et aliments ameliorant le metabolisme des lipides
KR20050071605A (ko) * 2002-10-21 2005-07-07 메타프로테오믹스, 엘엘씨 염증반응과 관련된 병리학적 상태를 치료하거나 저해하는조성물
JP2005104951A (ja) * 2003-01-17 2005-04-21 Kirin Brewery Co Ltd 血圧降下用組成物および血管柔軟性改善用組成物並びにこれらの機能が付与された食品
KR20060105429A (ko) * 2003-05-22 2006-10-11 메타프로테오믹스, 엘엘씨 염증을 약화시키기 위한 항염증성 약제학적 조성물 및 위의독성의 치료법 또는 예방법
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
WO2007021694A2 (en) * 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
JP2009518439A (ja) * 2005-12-09 2009-05-07 メタプロテオミクス，エルエルシー ホップ及びアカシア産物によるプロテインキナーゼ調節
EP2046353A4 (en) * 2006-06-20 2010-01-27 Metaproteomics Llc TREATMENT OF CANCER BY MODULATION OF PROTEIN KINASE, BASED ON ISO-ALPHA TETRAHYDRO ACIDS
US20080051466A1 (en) * 2006-06-20 2008-02-28 Metaproteomics, Llc Isoalpha acid based protein kinase modulation cancer treatment
US8815306B2 (en) * 2007-03-19 2014-08-26 Metaproteomics, Llc Methods and compositions for promoting bone and joint health
WO2008140842A1 (en) * 2007-05-11 2008-11-20 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
US20100137449A1 (en) * 2007-12-10 2010-06-03 Metaproteomics, Llc Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
AU2009231723B2 (en) * 2008-04-02 2014-04-17 Metaproteomics, Llc. Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892808A (en) * 1965-11-17 1975-07-01 Carlton & United Breweries Hop extracts
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US5370863A (en) * 1992-12-16 1994-12-06 Miller Brewing Company Oral care compositions containing hop acids and method
JPH06312924A (ja) * 1993-04-28 1994-11-08 Asahi Breweries Ltd 抗酸化作用を有するフムロン類の利用

Also Published As

Publication number Publication date
TW427901B (en) 2001-04-01
EP0677289A2 (en) 1995-10-18
EP0677289A3 (en) 1996-10-23
DK0677289T3 (da) 1999-09-06
HU9501043D0 (en) 1995-06-28
CA2146820A1 (en) 1995-10-13
NO951422D0 (no) 1995-04-11
ATE175575T1 (de) 1999-01-15
EP0677289B1 (en) 1999-01-13
FI951702A (fi) 1995-10-13
DE69507185D1 (de) 1999-02-25
AU696334B2 (en) 1998-09-10
ES2129691T3 (es) 1999-06-16
KR950031059A (ko) 1995-12-18
FI951702A0 (fi) 1995-04-10
DE69507185T2 (de) 1999-09-09
HUT71604A (en) 1996-01-29
US5604263A (en) 1997-02-18
AU1638495A (en) 1995-10-19

Similar Documents

Publication Publication Date Title
NO951422L (no) Farmasöytiske sammensetninger for behandling av osteoporose
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
AP2000001842A0 (en) Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists.
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
TWI256950B (en) Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
MY115339A (en) Compositions containing micronized nebivolol
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
HUP0102602A2 (hu) Diacil-hidrazinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
BG104630A (en) Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
BG104690A (en) Aqueous formulations of parasiticides for skin application
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
WO2003028475A1 (fr) Aliments pour animaux et engrais renfermant des triterpenes pentacycliques
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
AU3777197A (en) Cyclosporin formulation
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
MD1762B2 (ro) Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile
MXPA01004457A (es) Derivados pirimidina novedosos y procesos para la preparacion de los mismos.
NO991589L (no) Nye 3-,5- og/eller 6-substituerte analoger av swainsonin, fremgangsmÕter for deres fremstilling og deres anvendelse som terapeutiske midler
NO20022971L (no) Butyndiol-derivater
DK0989994T3 (da) Streptograminderivater, deres fremstilling og præparater, der indeholder dem
HUT64044A (en) Thiocarboxylic acid derivatives, process for producing same, plant growth regulating compositions comprising such compounds as active ingredient, their use, as well as intermediates of the active ingredients
EP0992242A4 (en) PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application